These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
15. Modeling the Downstream Processing of Monoclonal Antibodies Reveals Cost Advantages for Continuous Methods for a Broad Range of Manufacturing Scales. Hummel J; Pagkaliwangan M; Gjoka X; Davidovits T; Stock R; Ransohoff T; Gantier R; Schofield M Biotechnol J; 2019 Feb; 14(2):e1700665. PubMed ID: 29341493 [TBL] [Abstract][Full Text] [Related]
16. How development and manufacturing will need to be structured--heads of development/manufacturing. May 20-21, 2014 Continuous Manufacturing Symposium. Nepveux K; Sherlock JP; Futran M; Thien M; Krumme M J Pharm Sci; 2015 Mar; 104(3):850-64. PubMed ID: 25630721 [TBL] [Abstract][Full Text] [Related]
17. Continuous downstream processing for high value biological products: A Review. Zydney AL Biotechnol Bioeng; 2016 Mar; 113(3):465-75. PubMed ID: 26153056 [TBL] [Abstract][Full Text] [Related]
18. White Paper on Continuous Bioprocessing May 20-21 2014 Continuous Manufacturing Symposium. Konstantinov KB; Cooney CL J Pharm Sci; 2015 Mar; 104(3):813-820. PubMed ID: 28756843 [TBL] [Abstract][Full Text] [Related]
19. Aqueous two-phase systems: A viable platform in the manufacturing of biopharmaceuticals. Rosa PA; Ferreira IF; Azevedo AM; Aires-Barros MR J Chromatogr A; 2010 Apr; 1217(16):2296-305. PubMed ID: 19962707 [TBL] [Abstract][Full Text] [Related]
20. The Current Scientific and Regulatory Landscape in Advancing Integrated Continuous Biopharmaceutical Manufacturing. Fisher AC; Kamga MH; Agarabi C; Brorson K; Lee SL; Yoon S Trends Biotechnol; 2019 Mar; 37(3):253-267. PubMed ID: 30241924 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]